A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine
Clinical trial NCT03581903 · COMPLETED
Trial details
- NCT number
- NCT03581903
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2018-09-14
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.